Personas / Equipo Humano

Elena Rubio Abadal

Buscador de publicaciones

Publicaciones

  • del Cacho N, Butjosa A, Vila R, Cuadras-Palleja D, Kaplan M, Rubio E, Pardo M, Muñoz D, Cuevas-Esteban J, GERARDO SAENZ DE NAVARRETE RIBERA, PROFEP group and Usall J.

    Prolactin levels in drug-naive first episode nonaffective psychosis patients compared with healthy controls. Sex differences

    PSYCHIATRY RESEARCH . 276: 218-222. Nº de citas: 14

    [doi:10.1016/j.psychres.2019.03.027]

  • Alonso-Solís A, Rubinstein K, Corripio I, Jaaskelainen E, Seppälä A, Vella VA, Caro-Mendivelso J, Caspi A, Isohanni M, Unoka Z, Van der Graff S, Farkas K, Huerta-Ramos ME, Marcó-García S, Stevens M, Coenen T, Hospedales M, Berdún J, m-Resist group and Grasa EM.

    Mobile therapeutic attention for treatment-resistant schizophrenia (m-RESIST): a prospective multicentre feasibility study protocol in patients and their caregivers.

    BMJ Open . 8(7): . Nº de citas: 8

    [doi:10.1136/bmjopen-2017-021346]

  • Huerta-Ramos ME, Marcó-García S, Escobar-Villegas MS, Rubio E, Ochoa S, Grasa Bello EM, Alonso Solís A, Rabella M, Berdun J, Hospedales M, M-Resist G, Corripio I and Usall J.

    m-RESIST, a complete m-Health solution for patients with treatmentresistant schizophrenia: a qualitative study of user needs and acceptability in the Barcelona metropolitan area.

    ACTAS ESPANOLAS DE PSIQUIATRIA . 45(6): 277-289. Nº de citas: 4

  • Labad J, Martorell L, Huerta-Ramos ME, Cobo J, Vilella E, Rubio E, Garcia-Pares G, Creus M, Nuñez C, Ortega L, Miquel E, RALOPSYCAT Group and Usall J.

    Pharmacogenetic study of the effects of raloxifene on negative symptoms of postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial

    EUROPEAN NEUROPSYCHOPHARMACOLOGY . 26(10): 1683-1689. Nº de citas: 18

    [doi:10.1016/j.euroneuro.2016.08.006]

  • Rubio E, Usall J, Barajas A, Carlson J, Iniesta R, Huerta-Ramos ME, Baños I, Dolz M, Sánchez B and Ochoa S.

    Relationship between menarche and psychosis onset in women with first episode of psychosis

    EARLY INTERVENTION IN PSYCHIATRY . 10(5): 419-425. Nº de citas: 3

    [doi:10.1111/eip.12194]

  • Rubio E, del Cacho N, Saenz-Navarrete G, Arranz B, Cambra RM, Cuadras-Palleja D, Rodante D, Fehér C, Roca M, Barneda V, Usall J and PROLACT Group.

    How Hyperprolactinemia Affects Sexual Function in Patients Under Antipsychotic Treatment

    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY . 36(5): 422-428. Nº de citas: 21

    [doi:10.1097/JCP.0000000000000539]

  • Grau N, Rubio E, Usall J, Barajas A, Butjosa A, Dolz M, Baños I, Sánchez Fernández B, Rodríguez MJ, Peláez T, Sammut S, Carlson J, Huerta-Ramos ME, GENIPE Group and Ochoa S.

    Influence of cognition, premorbid adjustment and psychotic symptoms on psycho-social functioning in first-episode psychosis

    PSYCHIATRY RESEARCH . 242: 157-162. Nº de citas: 19

    [doi:10.1016/j.psychres.2016.04.121]

  • Huerta-Ramos ME, Escobar-Villegas MS, Rubinstein K, Unoka ZS, Grasa E, Hospedales M, Jääskeläinen E, Rubio E, Caspi A, Bitter I, Berdun J, Seppälä J, Ochoa S, Fazekas K, M-RESIST Group, Corripio I and Usall J.

    Measuring Users' Receptivity Toward an Integral Intervention Model Based on mHealth Solutions for Patients With Treatment-Resistant Schizophrenia (m-RESIST): A Qualitative Study

    JMIR mHealth and uHealth . 4(3): . Nº de citas: 17

    [doi:10.2196/mhealth.5716]

  • Rubio E, Saenz Navarrete, G., Arranz B, Del Cacho, N., Cambra, R., Iniesta, R., Roca, M., Barneda, V. and Usall J.

    Reproductive side effects of antipsychotic-induced hyperprolactinemia; a cross-sectional study - preliminary results

    EUROPEAN NEUROPSYCHOPHARMACOLOGY . 23(2): 462-462.

    [doi:10.1016/S0924-977X(13)70731-4]

  • Rubio E and Usall J.

    Hiperprolactinemia y tratamiento antipsicótico. Manifestaciones clínicas y manejo.

    Psiquiatría biológica . 20(3): 27-34.